Literature DB >> 1939237

Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.

F A Gonzalez1, D L Raden, R J Davis.   

Abstract

Two epidermal growth factor-stimulated protein kinases that correspond to ERK1 and ERK2 have been purified from human epidermoid carcinoma cells (Northwood, I. C., Gonzalez, F. A., Wartmann, M., Raden, D. L., and Davis, R. J. (1991) J. Biol. Chem. 266, 15266-15276). A consensus primary sequence for substrates of ERK1 has been identified as -Pro-Leu-Ser/Thr-Pro- (Alvarez, E., Northwood, I. C., Gonzalez, F. A., Latour, D. A., Seth, A., Abate, C., Curran, T., and Davis, R. J. (1991) J. Biol. Chem. 266, 15277-15285). However, the structural determinants for substrate recognition are not understood. We performed a systematic analysis of the effect of point mutations in the primary sequence of peptide substrates on the rate of phosphorylation by ERK1 and ERK2. The results of this investigation demonstrate that the substrate specificities of the ERK1 and ERK2 protein kinases are very similar. We propose that the primary sequence of substrates for ERK1 and ERK2 protein kinases can be generalized as -Pro-Xaan-Ser/Thr-Pro- (where Xaa is a neutral or basic amino acid and n = 1 or 2).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  137 in total

1.  Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase.

Authors:  G E Schafe; N V Nadel; G M Sullivan; A Harris; J E LeDoux
Journal:  Learn Mem       Date:  1999 Mar-Apr       Impact factor: 2.460

2.  Inhibition of c-Jun DNA binding by mitogen-activated protein kinase.

Authors:  S Y Chou; V Baichwal; J E Ferrell
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

3.  Examining docking interactions on ERK2 with modular peptide substrates.

Authors:  Sunbae Lee; Mangalika Warthaka; Chunli Yan; Tamer S Kaoud; Pengyu Ren; Kevin N Dalby
Journal:  Biochemistry       Date:  2011-10-18       Impact factor: 3.162

4.  Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.

Authors:  Esther Sook Miin Wong; Chee Wai Fong; Jormay Lim; Permeen Yusoff; Boon Chuan Low; Wallace Y Langdon; Graeme R Guy
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

5.  Pseudomonas syringae type III effector AvrPtoB is phosphorylated in plant cells on serine 258, promoting its virulence activity.

Authors:  Fangming Xiao; Patrick Giavalisco; Gregory B Martin
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

Review 6.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN.

Authors:  Mei-Ying Han; Hidetaka Kosako; Toshiki Watanabe; Seisuke Hattori
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

8.  High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.

Authors:  Ji Suk Chang; Ramasamy Santhanam; Rossana Trotta; Paolo Neviani; Anna M Eiring; Edward Briercheck; Mattia Ronchetti; Denis C Roy; Bruno Calabretta; Michael A Caligiuri; Danilo Perrotti
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

Review 9.  MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.

Authors:  Demet Candas; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2013-06-08       Impact factor: 8.401

10.  Biochemical and biological analysis of Mek1 phosphorylation site mutants.

Authors:  W Huang; D S Kessler; R L Erikson
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.